Vita Life Sciences Limited (ASX:VLS)

Vita Life Sciences Revenue

Vita Life Sciences had revenue of 48.31M AUD in the half year ending June 30, 2026, with 22.44% growth. This brings the company's total for the last twelve months to 96.03M, up 12.19% year-over-year. In the year 2025, Vita Life Sciences had annual revenue of 93.27M with 17.31% growth. That makes Vita Life Sciences the 25,722nd largest company in the world by revenue and 450th in Australia.

• Revenue (ttm): 96.03M
• Revenue Growth: +12.19%
• P/S Ratio: 1.57
• Revenue / Employee: 274.37K
• Employees: 350
• Market Cap: 150.84M

Revenue Chart

Chart

Chart

Revenue by Segment

Chart

• Vms Operational - Malaysia & Singapore 44.81M 48.0%
• Vms Operational - Australia 40.53M 43.5%
• Vms Investment - China & Vietnam 7.93M 8.5%

Fiscal year ended Dec 31, 2025 See the full Vita Life Sciences breakdown

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	93.27M	13.77M	17.31%
Dec 31, 2024	79.51M	6.08M	8.28%
Dec 31, 2023	73.43M	6.54M	9.78%
Dec 31, 2022	66.89M	9.78M	17.14%
Dec 31, 2021	57.10M	10.62M	22.85%

Data Source: S&P Global Market Intelligence Last updated: Aug 17, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every six months for this company.

Update frequency:

Semi-annually

Last checked:

Oct 18, 2026

Data Sources Report a data error